Chesson, Harrell W <br/><br/>
The impact and cost-effectiveness of nonavalent HPV vaccination in the United States: Estimates from a simplified transmission model.  [electronic resource] 

 -  Human vaccines & immunotherapeutics  06 2016 
 - 1363-72 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>2164-554X 
<br/><br/><label>Standard No.: </label>10.1080/21645515.2016.1140288  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Child<br/>Child, Preschool<br/>Cost-Benefit Analysis<br/>Disease Transmission, Infectious--prevention & control<br/>Female<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Male<br/>Middle Aged<br/>Papillomavirus Infections--economics<br/>Papillomavirus Vaccines--administration & dosage<br/>Treatment Outcome<br/>United States--epidemiology<br/>Vaccination--economics<br/>Young Adult